Search

Author/Creator Basappa, Naveen S

1. Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. Issue 3 (March 2023)

Authors:
Choueiri, Toni K; Eto, Masatoshi; Motzer, Robert; De Giorgi, Ugo; Buchler, Tomas; Basappa, Naveen S; Méndez-Vidal, María José; Tjulandin, Sergei; Hoon Park, Se; Melichar, Bohuslav; Hutson, Thomas; Alemany, Carlos; McGregor, Bradley; Powles, Thomas; Grünwald, Viktor; Alekseev, Boris; Rha, Sun Youn...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer. Issue 6 (1st October 2021)

Authors:
Wallis, Christopher J D; Malone, Shawn; Cagiannos, Ilias; Morgan, Scott C; Hamilton, Robert J; Basappa, Naveen S; Ferrario, Cristiano; Gotto, Geoffrey T; Fernandes, Ricardo; Niazi, Tamim; Noonan, Krista L; Saad, Fred; Hotte, Sebastien J; Hew, Huong; Chan, Katherine F Y; Wyllie, Laura Park; S...
Journal:
JNCI cancer spectrum
Issue:
Volume 5:Issue 6(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search